(Q50904556)

English

Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial.

scientific article published on 18 April 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Long-term survival after adoptive bone marrow T cell therapy of advanced metastasized breast cancer: follow-up analysis of a clinical pilot trial. (English)

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

11

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

object named as

Sarah Schott

4

0 references

Andreas Schneeweiss

13

object named as

Andreas Schneeweiss

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

author name string

Christoph Domschke

1

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Yingzi Ge

2

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Isa Bernhardt

3

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Sophia Keim

5

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Simone Juenger

6

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Mariana Bucur

7

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Luisa Mayer

8

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Maria Blumenstein

9

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Joachim Rom

10

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Christof Sohn

12

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Philipp Beckhove

14

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Florian Schuetz

15

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

publication date

18 April 2013

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

number of pages

8

1 reference

based on heuristic

inferred from page(s)

Cancer Immunology, Immunotherapy

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

62

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

6

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

1053-1060

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

https://scigraph.springernature.com/pub.10.1007/s00262-013-1414-x

0 references

Prognostic significance of occult lymph node metastases in node-negative breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Therapy of human tumors in NOD/SCID mice with patient-derived reactivated memory T cells from bone marrow.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Enrichment of functional CD8 memory T cells specific for MUC1 in bone marrow of patients with multiple myeloma.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

High frequencies of functional tumor-reactive T cells in bone marrow and blood of pancreatic cancer patients.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Intratumoral Cytokines and Tumor Cell Biology Determine Spontaneous Breast Cancer-Specific Immune Responses and Their Correlation to Prognosis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

T-cell priming in bone marrow: the potential for long-lasting protective anti-tumor immunity

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Two subsets of memory T lymphocytes with distinct homing potentials and effector functions

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

From synapses to immunological memory: the role of sustained T cell stimulation

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Cytokine-driven proliferation and differentiation of human naive, central memory, and effector memory CD4(+) T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Dynamic differentiation of activated human peripheral blood CD8+ and CD4+ effector memory T cells.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Acquisition of full effector function in vitro paradoxically impairs the in vivo antitumor efficacy of adoptively transferred CD8+ T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Central memory self/tumor-reactive CD8+ T cells confer superior antitumor immunity compared with effector memory T cells

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Treatment of advanced metastasized breast cancer with bone marrow-derived tumour-reactive memory T cells: a pilot clinical study

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

A human cell line from a pleural effusion derived from a breast carcinoma

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Goals of treatment for patients with metastatic breast cancer

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Overall survival and post-progression survival in advanced breast cancer: a review of recent randomized clinical trials

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Role of stromal-derived cytokines and growth factors in bone metastasis

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Transforming growth factor-beta regulation of immune responses

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Conversion of peripheral CD4+CD25- naive T cells to CD4+CD25+ regulatory T cells by TGF-beta induction of transcription factor Foxp3

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Role of tumor endothelium in CD4+ CD25+ regulatory T cell infiltration of human pancreatic carcinoma.

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Metronomic cyclophosphamide regimen selectively depletes CD4+CD25+ regulatory T cells and restores T and NK effector functions in end stage cancer patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Metronomic cyclophosphamide treatment in metastasized breast cancer patients: immunological effects and clinical outcome

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Specific lymphocyte subsets predict response to adoptive cell therapy using expanded autologous tumor-infiltrating lymphocytes in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Adoptive cell therapy with autologous tumor infiltrating lymphocytes and low-dose Interleukin-2 in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Clinical responses in a phase II study using adoptive transfer of short-term cultured tumor infiltration lymphocytes in metastatic melanoma patients

1 reference

https://api.crossref.org/works/10.1007%2FS00262-013-1414-X

21 January 2018

Identifiers

10.1007/S00262-013-1414-X

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

PubMed publication ID

1 reference

Europe PubMed Central

PubMed publication ID

25 March 2018

http://europepmc.org/abstract/MED/23595207

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q50904556&oldid=1767057541"